For instance, although PUMA expression does not correlate with tumour thickness in primary melanoma, it is further reduced in metastatic melanoma and weaker PUMA expression is correlated with a poorer 5-year patient survival (Karst et al, 2005). This evidence concerns the gene BBC3 and metastatic melanoma.